AU Stock MarketDetailed Quotes
1AD AdAlta Ltd
- 0.020
- +0.001+5.26%
20min DelayMarket Closed Oct 17 12:52 AET
12.12MMarket Cap-1818P/E (Static)
0.020High0.019Low52.95KVolume0.019Open0.019Pre Close1.03KTurnover0.04152wk High0.02%Turnover Ratio606.21MShares0.01652wk Low-0.011EPS TTM6.50MFloat Cap0.378Historical HighLossP/E (Static)324.99MShs Float0.016Historical Low-0.011EPS LYR5.26%Amplitude--Dividend TTM6.67P/B1Lot Size--Div YieldTTM
About AdAlta Ltd Company
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation protein and cell-based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.
Company Profile
Symbol1AD
Company NameAdAlta Ltd
Founded2006
MarketASX
Employees9
Fiscal Year Ends06-30
AddressScience Drive La Trobe Institute for Molecular Science, Room 204, LIMS2
CityBundoora
CountryAustralia
Zip Code3086
Phone+61 394795159
Websitehttps://www.adalta.com.au
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Timothy Oldham
- Managing Director,Chief Executive Officer
- --
- Paul MacLeman
- Executive Chairman,Executive Director
- --
- Robert Peach
- Non-Executive Director
- --
- David Fuller
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data